Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.03
-0.27 (-2.62%)
At close: Nov 16, 2026, 4:00 PM EST
10.18
+0.15 (1.50%)
After-hours: Nov 16, 2026, 7:30 PM EST

Keros Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1976206411,1911,3231,369
Market Cap Growth
-63.02%-3.27%-46.17%-9.94%-3.39%-16.27%
Enterprise Value
-48-561309181,0841,149
Last Close Price
10.3020.3615.8339.7648.0258.51

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-7.13----
PS Ratio
4.852.54180.637888.64-68.11
PB Ratio
0.732.051.123.594.775.63
P/TBV Ratio
0.712.051.123.594.775.63
P/FCF Ratio
-5.85----
P/OCF Ratio
-5.77----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--36.576076.87-57.16

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.060.030.040.050.00
Debt / EBITDA Ratio
-0.21----
Debt / FCF Ratio
-0.16----
Net Debt / Equity Ratio
-0.88-0.89-0.95-0.95-0.96-0.94
Net Debt / EBITDA Ratio
3.56-3.752.581.872.334.09
Net Debt / FCF Ratio
5.06-2.553.322.493.733.62
Asset Turnover
0.080.510.010-0.08
Quick Ratio
17.8415.1020.5613.6316.9220.96
Current Ratio
18.1415.4521.4514.2517.2721.23
Return on Equity (ROE)
-12.56%19.90%-41.46%-50.19%-40.22%-23.27%
Return on Assets (ROA)
-8.36%9.25%-26.73%-31.39%-25.53%-13.43%
Return on Invested Capital (ROIC)
-254.67%211.85%-691.64%---396.30%
Return on Capital Employed (ROCE)
-24.10%22.20%-35.80%-49.20%-39.60%-23.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-28.49%14.03%-29.22%-12.84%-7.91%-4.29%
FCF Yield
-24.40%17.08%-25.39%-10.66%-5.39%-4.61%
Buyback Yield / Dilution
47.30%-1.13%-27.13%-16.66%-8.17%-50.48%
SEC Filings: 10-K · 10-Q